The  	The  	 DT	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	B-NP
factors  	factors  	 NNS	I-NP
in  	in  	 IN	O
G2  	G2  	 CD	B-NP
neuroendocrine  	neuroendocrine  	 JJ	I-NP
tumor  	tumor  	 NN	I-NP
The  	The  	 DT	O
G2  	G2  	 FW	B-NP
neuroendocrine  	neuroendocrine  	 FW	I-NP
tumors  	tumors  	 FW	I-NP
( 	( 	 -LRB-	O
NET 	NET 	 NNP	B-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
well-differentiated  	well-differentiated  	 JJ	O
neuroendocrine  	neuroendocrine  	 JJ	B-NP
carcinomas  	carcinomas  	 NNS	I-NP
( 	( 	 -LRB-	O
2010  	2010  	 CD	O
WHO  	WHO  	 WP	B-NP
Classification  	Classification  	 NNP	O
of  	of  	 IN	O
Tumours  	Tumours  	 NNP	O
of  	of  	 IN	O
the  	the  	 DT	O
Digestive  	Digestive  	 NNP	B-NP
System 	System 	 NNP	I-NP
)  	)  	 -RRB-	O
embrace  	embrace  	 VB	O
different  	different  	 JJ	O
types  	types  	 NNS	O
of  	of  	 IN	O
evolution  	evolution  	 NN	B-NP
despite  	despite  	 IN	O
the  	the  	 DT	O
fact  	fact  	 NN	O
that  	that  	 IN	O
they  	they  	 PRP	O
actually  	actually  	 RB	O
are  	are  	 VBP	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
group  	group  	 NN	O
of  	of  	 IN	O
prognosis  	prognosis  	 VBG	O
based  	based  	 VBN	O
on  	on  	 IN	O
mitotic  	mitotic  	 JJ	B-NP
count  	count  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
Ki-67  	Ki-67  	 JJ	B-NP
proliferation  	proliferation  	 NN	I-NP
index 	index 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
studied  	studied  	 VBD	O
the  	the  	 DT	O
pathological  	pathological  	 NN	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
aspects  	aspects  	 NNS	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
G2  	G2  	 NNP	B-NP
NET 	NET 	 NNP	I-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
a  	a  	 DT	O
retrospective  	retrospective  	 JJ	B-NP
pilot  	pilot  	 NN	I-NP
observational  	observational  	 NN	I-NP
study  	study  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
admitted  	admitted  	 VBN	O
between  	between  	 IN	O
January  	January  	 NNP	O
2008  	2008  	 CD	O
and  	and  	 CC	O
January  	January  	 NNP	O
2013  	2013  	 CD	O
in  	in  	 IN	O
Constantin  	Constantin  	 NNP	B-NP
I.  	I.  	 NNP	I-NP
Parhon  	Parhon  	 NNP	I-NP
National  	National  	 NNP	I-NP
Institute  	Institute  	 NNP	I-NP
of  	of  	 IN	I-NP
Endocrinology 	Endocrinology 	 NNP	I-NP
,  	,  	 ,	O
Bucharest 	Bucharest 	 NNP	B-NP
,  	,  	 ,	O
Romania 	Romania 	 NNP	B-NP
.  	.  	 .	O
They  	They  	 PRP	O
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
pathological  	pathological  	 JJ	B-NP
report 	report 	 NN	I-NP
,  	,  	 ,	O
imagistic  	imagistic  	 JJ	O
scan 	scan 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
neuroendocrine  	neuroendocrine  	 JJ	B-NP
markers 	markers 	 NN	I-NP
.  	.  	 .	O
Nine  	Nine  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
female 	female 	 JJ	B-NP
/ 	/ 	 CD	I-NP
male  	male  	 JJ	I-NP
ratio 	ratio 	 NN	I-NP
:  	:  	 :	O
5 	5 	 CD	O
/ 	/ 	 CD	O
4 	4 	 CD	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
G2  	G2  	 NNP	B-NP
NET  	NET  	 NNP	I-NP
were  	were  	 VBD	O
included  	included  	 VBN	O
( 	( 	 -LRB-	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
at  	at  	 IN	O
diagnosis  	diagnosis  	 CD	O
54.11  	54.11  	 CD	O
years 	years 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Surgery  	Surgery  	 NN	O
was  	was  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
66.66 	66.66 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
cases.  	cases.  	 CD	O
44.44 	44.44 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
tumors  	tumors  	 NNS	O
had  	had  	 VBD	O
unknown  	unknown  	 JJ	O
origin.  	origin.  	 CD	O
22.22 	22.22 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
negative  	negative  	 JJ	B-NP
immunostain  	immunostain  	 NN	I-NP
for  	for  	 IN	O
chromogranin  	chromogranin  	 JJ	O
A.  	A.  	 NNP	O
Synaptophysin  	Synaptophysin  	 NNP	B-NP
was  	was  	 VBD	O
positive  	positive  	 JJ	O
in  	in  	 IN	O
all  	all  	 DT	O
cases 	cases 	 NNS	O
.  	.  	 .	O
Neuronal  	Neuronal  	 JJ	B-NP
specific  	specific  	 JJ	I-NP
enolase  	enolase  	 NNS	I-NP
( 	( 	 -LRB-	O
NSE 	NSE 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
44.44 	44.44 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
cases  	cases  	 NNS	O
and  	and  	 CC	O
it  	it  	 PRP	O
was  	was  	 VBD	O
positive  	positive  	 JJ	O
in  	in  	 IN	O
all  	all  	 PDT	O
these  	these  	 DT	O
situations.  	situations.  	 CD	O
88.88 	88.88 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
high  	high  	 JJ	O
neuroendocrine  	neuroendocrine  	 JJ	B-NP
markers 	markers 	 NN	I-NP
.  	.  	 .	O
Multiple  	Multiple  	 JJ	B-NP
tumors  	tumors  	 NNS	I-NP
were  	were  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
two  	two  	 CD	O
cases  	cases  	 NNS	O
( 	( 	 -LRB-	O
follicular  	follicular  	 FW	B-NP
thyroid  	thyroid  	 FW	I-NP
adenoma 	adenoma 	 FW	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
carcinoma  	carcinoma  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
port  	port  	 JJ	I-NP
vein 	vein 	 NN	I-NP
,  	,  	 ,	O
respective  	respective  	 FW	O
bilaterally  	bilaterally  	 FW	O
pheochromocytomas 	pheochromocytomas 	 FW	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
youngest  	youngest  	 JJS	O
patient  	patient  	 NN	O
( 	( 	 -LRB-	O
39-year-old 	39-year-old 	 NNP	O
)  	)  	 -RRB-	O
had  	had  	 VBD	O
atypical  	atypical  	 JJ	O
onset  	onset  	 NN	O
with  	with  	 IN	O
bilateral  	bilateral  	 JJ	B-NP
adrenal  	adrenal  	 JJ	I-NP
tumors  	tumors  	 NNS	I-NP
( 	( 	 -LRB-	O
positive  	positive  	 JJ	O
for  	for  	 IN	O
CHROMO 	CHROMO 	 NNP	B-NP
,  	,  	 ,	O
EMA 	EMA 	 NNP	B-NP
,  	,  	 ,	O
CK-19 	CK-19 	 NNP	B-NP
,  	,  	 ,	O
CK-20 	CK-20 	 NNP	B-NP
,  	,  	 ,	O
negative  	negative  	 JJ	O
for  	for  	 IN	O
SOMATO 	SOMATO 	 NNP	B-NP
,  	,  	 ,	O
CK-7 	CK-7 	 NNP	B-NP
,  	,  	 ,	O
S-100 	S-100 	 NNP	B-NP
,  	,  	 ,	O
glucagon 	glucagon 	 NN	B-NP
,  	,  	 ,	O
CD57 	CD57 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
Ki-67  	Ki-67  	 NN	B-NP
of  	of  	 IN	O
15 	15 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Death  	Death  	 NN	O
was  	was  	 VBD	O
registered  	registered  	 VBN	O
in  	in  	 IN	O
two  	two  	 CD	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
both  	both  	 DT	O
with  	with  	 IN	O
bone  	bone  	 NN	B-NP
metastases 	metastases 	 NN	I-NP
.  	.  	 .	O
Some  	Some  	 DT	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	B-NP
factors  	factors  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
taken  	taken  	 VBN	O
into  	into  	 IN	O
account  	account  	 NN	O
as  	as  	 IN	O
lack  	lack  	 NN	O
of  	of  	 IN	O
CHROMO  	CHROMO  	 NNP	B-NP
immunostain 	immunostain 	 NN	I-NP
,  	,  	 ,	O
young  	young  	 JJ	O
age  	age  	 NN	O
at  	at  	 IN	O
diagnosis 	diagnosis 	 NN	O
,  	,  	 ,	O
genetic  	genetic  	 JJ	B-NP
background 	background 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
lack  	lack  	 NN	O
of  	of  	 IN	O
therapy  	therapy  	 NN	B-NP
options  	options  	 NNS	I-NP
as  	as  	 IN	O
surgery 	surgery 	 NN	O
.  	.  	 .	O
Larger  	Larger  	 JJR	O
databases  	databases  	 NNS	O
will  	will  	 MD	O
provide  	provide  	 VB	O
more  	more  	 JJR	O
information 	information 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
possible  	possible  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
G2  	G2  	 NNP	B-NP
NET  	NET  	 NNP	I-NP
group  	group  	 NN	I-NP
of  	of  	 IN	O
tumors  	tumors  	 NNS	O
actually  	actually  	 RB	O
includes  	includes  	 VBZ	O
some  	some  	 DT	O
different  	different  	 JJ	O
subtypes  	subtypes  	 NN	B-NP
or  	or  	 CC	O
in  	in  	 IN	O
fact 	fact 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
late  	late  	 JJ	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
might  	might  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
poor  	poor  	 JJ	O
diagnosis 	diagnosis 	 NN	O
.  	.  	 .	O
